Performance of 18F-Fluciclovine PET/CT for detection of recurrent prostate cancer, with a focus on low PSA levels (< 1 ng/mL): A single institution experience.

被引:0
|
作者
Sue, Veronia [1 ]
Brown, Adam [1 ]
Mittra, Erik [2 ]
Mallak, Nadine [1 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Stanford Univ, Radiol, Stanford, CA 94305 USA
来源
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1246
引用
收藏
页数:1
相关论文
共 50 条
  • [1] 18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL
    Garza, Daniel
    Kandathil, Asha
    Xi, Yin
    Subramaniam, Rathan M.
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (08) : 907 - 913
  • [2] Positive Findings on 18F-fluciclovine PET/CT in Patients with Suspected Recurrent Prostate Cancer and PSA levels ≤ 0.5 and ≤ 0.3 ng/ml
    Lovec, P.
    Savir-Baruch, B.
    Gupta, G.
    Wagner, R.
    Gabriel, M. S.
    Harkenrider, M. M.
    Solanki, A. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S161 - S161
  • [3] Utility of 18F-Fluciclovine PET/CT for Detecting Prostate Cancer Recurrence in Patients With Low (< 1 ng/mL) or Very Low (< 0.3 ng/mL) Prostate-Specific Antigen Levels
    Wang, Yingbing
    Chow, David Z.
    Ebert, Emily
    Tajmir, Shahein
    Scott, James A.
    Palmer, Edwin L.
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (04) : 997 - 1001
  • [4] Solitary Penile Metastasis of Prostate Cancer on 18F-Fluciclovine PET/CT Imaging in a Patient With PSA of 1 ng/mL
    Salavati, Ali
    Schik, Allyssa N.
    Koksel, Yasemin
    Gencturk, Mehmet
    Froelich, Jerry W.
    [J]. CLINICAL NUCLEAR MEDICINE, 2020, 45 (05) : 389 - 391
  • [5] 18F-Fluciclovine PET/CT Detection of Recurrent Prostate Carcinoma in Patients With Serum PSA ≤ 1 ng/mL After Definitive Primary Treatment
    England, Joseph R.
    Paluch, Jeremy
    Ballas, Leslie K.
    Jadvar, Hossein
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (03) : e128 - e132
  • [6] Diagnostic performance of 18F-Fluciclovine PET/CT in biochemical recurrent prostate cancer patients with low PSA values
    Lavelli, V.
    Nappi, A. G.
    Ferrari, C.
    Merenda, N. C.
    Santo, G.
    Scaltrito, C.
    Rubini, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S448 - S449
  • [7] Clinical utility of 18F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels
    Marcus, Charles
    Abiodun-Ojo, Olayinka A.
    Jani, Ashesh B.
    Schuster, David M.
    [J]. AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 11 (05): : 406 - 414
  • [8] PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer
    Crocerossa, Fabio
    Carbonara, Umberto
    Parekh, Jayashree
    Urdaneta, Alfredo
    Weprin, Samuel
    Damiano, Rocco
    Grob, Mayer B.
    Hampton, Lance J.
    Paul, Asit
    Autorino, Riccardo
    Cantiello, Francesco
    [J]. UROLOGIA INTERNATIONALIS, 2021, : 920 - 927
  • [9] Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI
    Selnaes, Kirsten Margrete
    Kruger-Stokke, Brage
    Elschot, Mattijs
    Johansen, Hakon
    Steen, Per Arvid
    Langorgen, Sverre
    Aksnessaether, Bjorg Yksnoy
    Indrebo, Gunnar
    Sjobakk, Torill Anita Eidhammer
    Tessem, May-Britt
    Moestue, Siver Andreas
    Knobel, Heidi
    Tandstad, Torgrim
    Bertilsson, Helena
    Solberg, Arne
    Bathen, Tone Frost
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [10] Review of 18F-Fluciclovine PET for Detection of Recurrent Prostate Cancer
    Gusman, Mariya
    Aminsharifi, Jamie A.
    Peacock, Justin G.
    Anderson, Shane B.
    Clemenshaw, Michael N.
    Banks, Kevin P.
    [J]. RADIOGRAPHICS, 2019, 39 (03) : 822 - 841